Views & Analysis
R&D/ Views & Analysis/ Views and analysis
New countries stockpile antiviral TPOXX as monkeypox outbreak continues
Jonah Comstock
monkeypox, orthopox, Philip Gomez, SIGA technologies, vaccines
0 Comment
Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis
Evaluate’s Orphan Drug Report shows rapid acceleration in the space
Jessica Hagen
Andreas Hadjivasiliou, Evaluate, Orphan Drug Report, orphan drugs, Paul Verdin
0 Comment
Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis
FDA’s treatment of China-developed drugs spurs demands for multiregional clinical trials
Ben Hargreaves
biologic medicines, China, fda, Lilly
0 Comment
R&D/ Views & Analysis/ Views and analysis
Combating antimicrobial resistance with a viable alternative to traditional antibiotics
mike.hammerton@pharmaphorum.com
AMR, anti microbial resistance, antibacterial resistance, Micreos Pharmaceuticals, MRSA
0 Comment
R&D/ Views & Analysis/ Views and analysis
Can technology help diversify clinical trials?
mike.hammerton@pharmaphorum.com
clinical trials, decentralised clinical trials, diversity, diversity and inclusion, KPMG
0 Comment
R&D/ Views & Analysis/ Views and analysis
Why are clinical trials struggling with diversity?
mike.hammerton@pharmaphorum.com
clinical trial diversity, clinical trials, COVID-19, diversity, diversity and inclusion, randomised control trials
0 Comment
Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis
Conducting successful commercial research in a primary care setting
Eloise McLennan
clinical trials, GSK, Healum, NIHR, primary care
0 Comment